Physician profile
Roopal G Rammohan
NPI 1508806977
$6,509.03
in general payments reported to CMS, 2019-2025
21 companies · $2,678 in 2025
The $2,678 reported for 2025 was more than what 98% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $389 · 2020: $168 · 2021: $353 · 2022: $634 · 2023: $712 · 2024: $1,575 · 2025: $2,678.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,031 · Travel and Lodging: $1,934.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,030.78 |
| Travel and Lodging | $1,934.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $1,925.15 | 2019-2025 | Clariti Contact Lens, Myday Contact Lens, Onefit Contact Lens |
| Oculus, INC. | $802.63 | 2024 | Na |
| Sun Pharmaceutical Industries INC. | $707.19 | 2019-2025 | Cequa |
| Bausch & Lomb Americas INC. | $538.11 | 2022-2025 | Xiidra, Miebo |
| Alcon Vision LLC | $422.12 | 2020-2025 | Total30, Tryptyr |
| Tarsus Pharmaceuticals, INC. | $379.72 | 2024-2025 | Xdemvy |
| Amgen INC. | $249.48 | 2024 | Tepezza |
| Novartis Pharmaceuticals Corporation | $241.64 | 2019-2022 | |
| Dompe US, INC. | $233.04 | 2024-2025 | Oxervate |
| Oyster Point Pharma, INC. | $208.84 | 2022-2024 | Tyrvaya |
| Lkc Technologies, INC. | $161.69 | 2025 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $125.45 | 2019 | |
| Glaukos Corporation | $124.80 | 2022 | |
| Johnson & Johnson Vision Care, INC. | $107.02 | 2021-2024 | Acuvue |
| Rayner Intraocular Lenses Limited | $93.01 | 2025 | Rayone Aspheric, Rayone Spheric, Rayner Cataract Set 1 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $81.90 | 2023 | |
| Sight Sciences, INC. | $33.18 | 2023 | Tearcare System |
| Abbvie INC. | $20.72 | 2022 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 | |
| Quidel Corporation | $16.70 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roopal Rammohan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.